Cooper A J, Lai J C
Neurochem Pathol. 1987 Feb-Apr;6(1-2):67-95. doi: 10.1007/BF02833601.
Brain ammonia is generated from many enzymatic reactions, including glutaminase, glutamate dehydrogenase, and the purine nucleotide cycle. In contrast, the brain possesses only one major enzyme for the removal of exogenous ammonia, i.e., glutamine synthetase. Thus, following administration of [13N]ammonia to rats [via either the carotid artery or cerebrospinal fluid (csf)], most metabolized label was in glutamine (amide) and little was in glutamate (plus aspartate). Since blood-and csf-borne ammonia are converted to glutamine largely, if not entirely, in the astrocytes, it is not possible from these types of experiments to predict with certainty the metabolic fate of the bulk of endogenously produced ammonia. By comparing the specific activity of L-[13N]glutamate to that of L-[amine-13N]glutamine following intracarotid [13N]ammonia administration it was concluded that metabolic compartmentation is no longer intact in the brains of rats treated with the glutamine synthetase inhibitor L-methionine-SR-sulfoximine (MSO) and that blood and brain ammonia pools mix in such animals. In MSO-treated animals, recovery of label in brain was low (approximately 20% of controls), and of the label remaining, a prominent portion was in glutamine (amide) (despite an 87% decrease in brain glutamine synthetase activity). These data are consistent with the hypothesis that glutamine synthetase is the major enzyme for metabolism of endogenously--as well as exogenously--produced ammonia. The rate of turnover of blood-derived ammonia to glutamine in normal rat brain is extremely rapid (t1/2 less than or equal to 3 s), but is slowed in the brains of chronically (12-14-wk portacaval-shunted) or acutely (urease-treated) hyperammonemic rats (t1/2 less than or equal to 10 s). The slowed turnover rate may be caused by an increased astrocytic ammonia, decreased glutamine synthetase activity, or both. In the hyperammonemic rat brain, glutamine synthetase is still the only important enzyme for the removal of blood-borne ammonia. Hyperammonemia causes an increase in brain lactate/pyruvate ratios and decreases in brain glutamate and brainstem ATP, consistent with an interference with the malate-aspartate shuttle. In vitro, pathological levels of ammonia also inhibit brain alpha-ketoglutarate dehydrogenase complex and, less strongly, pyruvate dehydrogenase complex. The rat brain does not adapt to prolonged hyperammonemia by increasing its glutamine synthetase activity.(ABSTRACT TRUNCATED AT 400 WORDS)
脑内氨由多种酶促反应产生,包括谷氨酰胺酶、谷氨酸脱氢酶和嘌呤核苷酸循环。相比之下,脑内仅有一种主要的酶用于清除外源性氨,即谷氨酰胺合成酶。因此,给大鼠经颈动脉或脑脊液(CSF)注射[13N]氨后,大部分代谢标记物存在于谷氨酰胺(酰胺)中,而谷氨酸(加天冬氨酸)中的含量很少。由于血液和脑脊液携带的氨在很大程度上(如果不是全部)在星形胶质细胞中转化为谷氨酰胺,因此从这些类型的实验中无法确切预测内源性产生的大部分氨的代谢命运。通过比较经颈动脉注射[13N]氨后L-[13N]谷氨酸与L-[胺-13N]谷氨酰胺的比活性,得出在用谷氨酰胺合成酶抑制剂L-蛋氨酸-SR-亚砜亚胺(MSO)处理的大鼠脑中,代谢区室化不再完整,并且在这些动物中血液和脑氨池混合。在经MSO处理的动物中,脑中标记物的回收率较低(约为对照组的20%),而在剩余的标记物中,很大一部分存在于谷氨酰胺(酰胺)中(尽管脑谷氨酰胺合成酶活性降低了87%)。这些数据与以下假设一致,即谷氨酰胺合成酶是内源性和外源性产生的氨代谢的主要酶。正常大鼠脑中血液来源的氨向谷氨酰胺的周转速度极快(半衰期小于或等于3秒),但在慢性(12 - 14周门腔分流)或急性(脲酶处理)高氨血症大鼠的脑中周转速度减慢(半衰期小于或等于10秒)。周转速度减慢可能是由于星形胶质细胞氨增加、谷氨酰胺合成酶活性降低或两者兼而有之。在高氨血症大鼠脑中,谷氨酰胺合成酶仍然是清除血液中氨的唯一重要酶。高氨血症导致脑乳酸/丙酮酸比值升高,脑谷氨酸和脑干ATP降低,这与对苹果酸 - 天冬氨酸穿梭的干扰一致。在体外,病理性氨水平也抑制脑α-酮戊二酸脱氢酶复合体,对丙酮酸脱氢酶复合体的抑制作用较弱。大鼠脑不会通过增加其谷氨酰胺合成酶活性来适应长期高氨血症。(摘要截短至400字)